What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
Eiji Miyoshi mainly focuses on Biochemistry, Fucosylation, Molecular biology, Fucose and Cell biology.
In his work, Cell surface receptor and Cell growth is strongly intertwined with Cell adhesion molecule, which is a subfield of Biochemistry.
The concepts of his Fucosylation study are interwoven with issues in Cancer, Internal medicine, Hepatocellular carcinoma, Endocrinology and Fucosyltransferase.
The study incorporates disciplines such as Cell culture, Gene and Transfection in addition to Molecular biology.
His Fucose research includes elements of Lectin and Blot.
His work carried out in the field of Cell biology brings together such families of science as Glycosylation, Integrin and Cell migration.
His most cited work include:
- Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma (669 citations)
- Dysregulation of TGF-β1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice (322 citations)
- Functional roles of N-glycans in cell signaling and cell adhesion in cancer. (291 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Molecular biology, Fucosylation, Biochemistry, Internal medicine and Immunology.
His Molecular biology study combines topics in areas such as Cell culture, Transfection, Gene expression, Messenger RNA and Antibody.
His Fucosylation research integrates issues from Cancer, Fucosyltransferases, Haptoglobin and Cell biology.
Eiji Miyoshi studied Cancer and Pathology that intersect with Hepatocellular carcinoma and Thyroid.
While the research belongs to areas of Internal medicine, Eiji Miyoshi spends his time largely on the problem of Endocrinology, intersecting his research to questions surrounding Carcinogenesis.
His studies in Immunology integrate themes in fields like Inflammatory bowel disease and Pancreatic cancer.
He most often published in these fields:
- Molecular biology (25.21%)
- Fucosylation (21.01%)
- Biochemistry (19.89%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (17.65%)
- Pancreatic cancer (11.76%)
- Fucosylation (21.01%)
In recent papers he was focusing on the following fields of study:
Eiji Miyoshi focuses on Internal medicine, Pancreatic cancer, Fucosylation, Immunology and Glycan.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Endocrinology.
His Pancreatic cancer research incorporates themes from Cancer research, Antibody and Haptoglobin.
His Fucosylation research incorporates elements of Prostate cancer, Fucosyltransferase and Bioinformatics.
Eiji Miyoshi combines subjects such as Tumor marker, Glycosylation and Disease with his study of Glycan.
His study in Cell biology is interdisciplinary in nature, drawing from both Receptor and Fucose.
Between 2015 and 2021, his most popular works were:
- Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer (67 citations)
- Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease (41 citations)
- Site-specific and linkage analyses of fucosylated N -glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer (23 citations)
In his most recent research, the most cited papers focused on:
Eiji Miyoshi mostly deals with Fucosylation, Immunology, Cancer, Internal medicine and Glycosylation.
His Fucosylation research incorporates elements of Toll-like receptor and Fucosyltransferase.
His Immunology research is multidisciplinary, incorporating elements of Molecular biology and Inflammatory bowel disease.
His Internal medicine research focuses on Gastroenterology and how it connects with Biomarker, Pancreas and Subclinical infection.
His Glycosylation study combines topics from a wide range of disciplines, such as Cancer cell, Lectin and N-linked glycosylation, Glycan.
His research investigates the connection between Pancreatic cancer and topics such as Cancer biomarkers that intersect with issues in Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
